• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Crypto Highlights: 69,000 BTC Sale, XRP's Price Analysis, Gensler's Comments

user avatar

by Giorgi Kostiuk

10 months ago


Recent developments in the crypto world include the US government's decision to sell a large amount of Bitcoin, XRP's price analysis amid market fluctuations, and Gensler's remarks on the industry.

US Government's Sale of 69,000 BTC

The U.S. government has been granted permission to liquidate 69,370 Bitcoins seized from the Silk Road marketplace. The lawsuit primarily aims to reveal the identity of 'Individual X,' the hacker involved in forfeiting the stolen Bitcoins. With the court's approval to proceed with the liquidation, concerns arise over the potential negative impact on Bitcoin's price, which is already struggling.

XRP Price Testing and Potential Outlook

The price of XRP recently faced a significant challenge, finding a bottom at the 20-day moving average. After a recent decline of 6.2%, XRP managed to stay above the median Bollinger Band and even experienced a brief rebound. However, broader market declines caused a subsequent drop. If XRP successfully retests above the median, a significant price increase could follow.

Gensler's Comments on Crypto Future

In his final days as chair of the U.S. SEC, Gary Gensler reiterated his concerns about the crypto industry, arguing that many projects lack fundamental support and are driven by sentiment. He mentioned that despite being well-informed about Bitcoin, the public faces risks with numerous ventures that may not survive in the long term.

The crypto market continues to grapple with significant developments that could heavily influence its trajectory. The sale of seized BTC, XRP's price volatility, and Gensler's comments create a complex environment, promising intriguing developments in the near future.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

BioAge Labs Focuses on Metabolic Aging with AI

chest

BioAge Labs is utilizing machine learning to explore metabolic aging and develop treatments for metabolic disorders.

user avatarAyman Ben Youssef

Neumora Therapeutics Targets Brain Diseases with AI

chest

Neumora Therapeutics is developing AI-driven solutions for treating brain diseases, including schizophrenia and Alzheimer's.

user avatarSon Min-ho

Relay Therapeutics Innovates Drug Discovery with AI

chest

Relay Therapeutics is using its AI-powered platform to enhance drug discovery processes in oncology.

user avatarJacob Williams

AI Advances in Biotech: Nobel Prize Winners and Promising Companies

chest

In 2024, the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John Jumper for their groundbreaking work in using machine learning to design entirely new proteins, highlighting the growing role of AI in biotech.

user avatarTando Nkube

OBBBA Law Restores R&D Deductions for Biotech Companies

chest

The One Big Beautiful Bill Act restores 100% deduction of R&D expenses for biotech companies, aimed at revitalizing domestic industries and reducing financial pressure.

user avatarZainab Kamara

Launch of OTCfi Token on Olympus Chain

chest

Launch of OTCfi Token on Olympus Chain as part of the partnership between Metavesco and BLAQclouds, aimed at expanding utility in crypto and OTC markets.

user avatarAisha Farooq

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.